Overseas manufacturing, the low price of generics and other factors lead to a shortage of important drugs for cancer and ...
drug shortages were the highest they had been in five years, according to a March 2023 Senate report. In terms of what caused the shortages, a new report from the Milken Center for Public Health ...
Editor’s Comment, Nelda Murri, PharmD: The public health consequences of national drug shortages are sobering ... following the announcement of a new drug shortage. One author has estimated ...
Here is what you need to know about drug shortages and how they affect care. In May, drug manufacturer Teva said it will ...
By Christina Jewett Thousands of patients are facing delays in getting treatments for cancer and other life-threatening diseases, with drug shortages in the United States approaching record levels.
Through the first three months of the quarter, there were 301 active national drug shortages ... report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security ...
Widespread shortages of cancer drugs are forcing doctors to make difficult decisions about how to treat their patients, ...
The drug shortage is due to manufacturing issues, delays in production, suppliers mishandling materials and the ...
A substantial number of physicians suspect there may be market manipulation behind at least some of the shortages. A report to the ... of an unavailable drug. The risk of errors is increased ...
A recent report from the U.S. Senate Committee on Homeland Security and Governmental Affairs identified 295 active drug shortages ... suppliers could pose a national security risk.
including nearly 50 new shortages that accumulated in the first three months of the year. The last time active drug shortages – including both newly reported and ongoing – were this high was ...
Thousands of patients are facing delays in getting treatments for cancer and other life-threatening diseases, with drug shortages ... from the New York Times The shortages are so acute that ...
